Incidence and Predictors of Recurrence and Mortality Following First Venous Thromboembolism Among the Saudi Population: Single-Center Cohort Study
Fahad A S AlEidan,Reem K AlManea,Alyah T AlMoneef,Nada A Shalash,Norah A AlRajhi,Sarah F AlMousa,Abdulrahman Al Raizah,Khadega A Abuelgasim
DOI: https://doi.org/10.2147/IJGM.S359893
IF: 2.145
2022-09-28
International Journal of General Medicine
Abstract:Fahad A S AlEidan, 1, 2 Reem K AlManea, 2 Alyah T AlMoneef, 2 Nada A Shalash, 2 Norah A AlRajhi, 2 Sarah F AlMousa, 2 Abdulrahman Al Raizah, 1– 3 Khadega A Abuelgasim 1, 2 1 King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; 2 College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 3 King Abdullah International Medical Research Center, Saudi Society for Bone Marrow Transplant, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia Correspondence: Fahad A S AlEidan, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, Tel +966118011111, Email Background: Little is written about recurrence and mortality rates after a first episode of venous thromboembolism (VTE) among Saudi population. Aim: Determine incidence rates and assess predictors of recurrence and mortality following the first VTE event. Patients and Methods: A total of 1124 patients aged ≥ 18 years with symptomatic VTE confirmed by imaging tests were evaluated. The incidence of VTE recurrence and mortality were assessed. The association between patient characteristics, and VTE recurrence and mortality was explored by estimating the hazard ratio (HR) and 95% confidence interval (CI). The difference between cancer-related, provoked and unprovoked VTE in terms of recurrence and mortality was explored using Kaplan–Meier curves. Results: The annual incidence rate of the first VTE was 1.7 per 1000 patients. Of 1124 patients with first VTE, 214 (19%) developed recurrent VTE, and 192 (17%) died with overall incidence rates of 15.8 per 100 person-years (95% CI, 13.8– 18.0) and 10.0 per 100 person-years (95% CI, 8.7– 11.5). Intensive care unit (ICU) admission (HR, 2.15; 95% CI, 1.67– 3.10), presence of active cancer (HR, 2.97; 95% CI, 1.87– 3.95), immobilization (HR, 2.52; 95% CI, 1.79– 3.67), infection (HR, 2.32; 95% CI, 1.94– 3.45), and pulmonary embolism ± deep venous thrombosis (HR, 2.22; 95% CI, 1.56– 3.16) were found to be independent predictors of recurrent VTE. Recurrence carries a high hazard of mortality (HR, 5.21; 95% CI, 3.61– 7.51). The estimated median time to VTE recurrence was lower in cancer-related VTE (18.7 months) compared with provoked (29.0 months) and unprovoked VTE (28.4 months). The estimated survival median time was lower in cancer-related VTE (21.8 months) compared with provoked (30.5 months) and unprovoked VTE (29.8 months). Conclusion: Immobilization and presence of active cancer, infection, and PE ± DVT were significant predictors of recurrent VTE. Patients who developed recurrent VTE had a 5.2-fold higher hazard of mortality compared with patients with no VTE recurrence. Keywords: incidence, mortality, predictors, recurrent, venous thromboembolism, active cancer Venous thromboembolism (VTE) is a condition comprising deep venous thrombosis (DVT) and pulmonary embolism (PE). PE occurs due to a blood clot wedged into one of the arteries of the lungs. 1 DVT occurs due to a blood clot development in the deep veins, most commonly originating in the lower limb, and can also originate in the pelvis and upper limb. 2–5 The annual incidence rate of the first VTE ranges from 1 to 3 per 1000. 6 Prior studies reported rates of recurrence and mortality after first VTE ranging from 5% to 40% 7–10 and from 3% to 30%, 11–15 respectively. These variations may have been influenced by different elements, such as study design, conduction setting (community or hospital), and/or the type and duration of anticoagulants used. The VTE events tend to recur in the presence of several predictors in individuals with a first VTE, including older age, male sex, obesity, site of index VTE, categorization of index VTE, history of VTE, family history of prior VTE, chronic heart disease, thrombophilia, inflammatory bowel disease, active cancer, and chronic heart disease. 3,7,12–19 The incidence rates, predictors of recurrence, and mortality after the first VTE among the Saudi population are unknown. To fill this knowledge gap, we conducted a cohort study to determine the incidence rates and to explore the predictors associated with recurrence and mortality events after the first VTE. A retrospective, single-center cohort study was conducted from January 2016 to December 2019 at King Abdulaziz Medical City (KAMC), a tertiary care hospital, Riyadh, Saudi Arabia. All adult patients with a confirmed first VTE (ie, those with DVT, PE, or both) were followed up for 36 months. The study was approved by the institutional review board at King -Abstract Truncated-
medicine, general & internal